Is low VLDL cholesterol normal?

Low VLDL cholesterol (under 30 mg/dL) is generally normal and healthy, as VLDL carries triglycerides that can contribute to heart disease. However, extremely low levels may occasionally indicate underlying health issues that warrant investigation.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding VLDL Cholesterol

Very low-density lipoprotein (VLDL) cholesterol is one of the five major types of lipoproteins that transport fats and cholesterol throughout your bloodstream. While you might be familiar with LDL (bad cholesterol) and HDL (good cholesterol), VLDL plays a unique role in your cardiovascular health that's worth understanding.

VLDL particles are produced by your liver and primarily carry triglycerides—a type of fat your body uses for energy. As VLDL particles travel through your bloodstream and deliver triglycerides to your tissues, they gradually transform into LDL cholesterol. This transformation makes VLDL an important precursor to LDL, which is why monitoring VLDL levels can provide valuable insights into your overall cardiovascular risk profile.

The Role of VLDL in Your Body

Your liver produces VLDL particles as a way to transport excess energy in the form of triglycerides to your muscles and fat tissue. This process is essential for energy distribution throughout your body. However, when VLDL levels become elevated, these particles can contribute to the buildup of plaque in your arteries, increasing your risk of heart disease and stroke.

VLDL Cholesterol Levels and Health Implications

VLDL Level (mg/dL)CategoryHealth ImplicationsRecommended Action
Below 2<2 mg/dLVery LowMay indicate malabsorption or metabolic issuesConsult healthcare provider if accompanied by symptoms
2-202-20 mg/dLOptimalExcellent cardiovascular healthMaintain healthy lifestyle
21-3021-30 mg/dLNormalAcceptable cardiovascular riskContinue monitoring
31-4031-40 mg/dLBorderline HighIncreased cardiovascular riskLifestyle modifications recommended
Above 40>40 mg/dLHighSignificant cardiovascular riskMedical evaluation and treatment needed

VLDL levels should be interpreted alongside complete lipid profile and clinical context.

What Are Normal VLDL Levels?

Normal VLDL cholesterol levels typically range from 2 to 30 mg/dL (0.05 to 0.78 mmol/L). Since VLDL isn't directly measured in standard lipid panels, it's usually estimated as approximately 20% of your triglyceride level. This estimation works because VLDL particles are the primary carriers of triglycerides in your blood.

When your VLDL levels fall below this range, you have what's considered low VLDL cholesterol. Unlike high VLDL levels, which are associated with increased cardiovascular risk, low VLDL levels are generally viewed as beneficial for heart health. In fact, having lower VLDL cholesterol often indicates that your body is efficiently processing fats and maintaining healthy triglyceride levels.

How VLDL Is Calculated

Since direct VLDL measurement requires specialized testing that's not routinely performed, healthcare providers typically calculate VLDL using the Friedewald equation: VLDL = Triglycerides ÷ 5 (when measured in mg/dL). This calculation assumes a standard ratio between triglycerides and VLDL, which holds true for most people when triglyceride levels are below 400 mg/dL.

Is Low VLDL Cholesterol Healthy?

In most cases, low VLDL cholesterol is not only normal but actually desirable. Since VLDL particles contribute to atherosclerosis (hardening of the arteries) and cardiovascular disease, having lower levels generally means reduced risk for these conditions. People with low VLDL cholesterol often have healthier overall lipid profiles, including lower triglycerides and better HDL to LDL ratios.

Research has consistently shown that individuals with lower VLDL levels tend to have better cardiovascular outcomes. A study published in the Journal of Clinical Lipidology found that people with VLDL cholesterol levels below 20 mg/dL had significantly lower rates of coronary artery disease compared to those with higher levels. This protective effect appears to be independent of other cholesterol markers, highlighting the importance of VLDL as a cardiovascular risk factor.

Benefits of Low VLDL

  • Reduced risk of atherosclerosis and plaque formation
  • Lower likelihood of developing heart disease
  • Better overall metabolic health
  • Improved insulin sensitivity
  • Decreased inflammation in blood vessels

What Causes Low VLDL Cholesterol?

Several factors can contribute to low VLDL cholesterol levels, most of which are related to healthy lifestyle choices and optimal metabolic function. Understanding these causes can help you maintain or achieve healthy VLDL levels while also identifying when low levels might warrant further investigation.

Lifestyle Factors

A healthy diet low in saturated fats and refined carbohydrates is one of the most effective ways to maintain low VLDL levels. When you consume fewer simple sugars and processed foods, your liver produces less VLDL because there's less excess energy to package and transport. Regular physical activity also plays a crucial role, as exercise helps your muscles use triglycerides more efficiently, reducing the need for VLDL production.

Maintaining a healthy weight is another key factor. People at optimal body weight typically have lower VLDL levels because their fat cells aren't overloaded and their metabolic processes function more efficiently. Additionally, moderate alcohol consumption or abstaining from alcohol altogether can help keep VLDL levels low, as excessive alcohol intake stimulates triglyceride production in the liver.

Medical and Genetic Factors

Some people naturally have low VLDL levels due to genetic variations that affect lipid metabolism. These genetic differences can influence how efficiently the liver produces and clears VLDL particles. Certain medications, particularly statins and fibrates used to treat high cholesterol, can also lower VLDL levels as part of their lipid-lowering effects.

In rare cases, extremely low VLDL levels might indicate underlying health conditions such as hyperthyroidism, malnutrition, or malabsorption disorders. These conditions can interfere with the body's ability to produce or process lipoproteins normally. If your VLDL levels are unusually low alongside other abnormal lab results or symptoms, your healthcare provider may investigate these possibilities.

When Should You Be Concerned About Low VLDL?

While low VLDL cholesterol is generally beneficial, extremely low levels—particularly when accompanied by other symptoms or abnormal lab results—may occasionally signal underlying health issues. If your VLDL is consistently below 2 mg/dL or your triglycerides are below 35 mg/dL, it's worth discussing with your healthcare provider.

Potential Concerns with Very Low VLDL

  • Malabsorption disorders affecting fat absorption
  • Hyperthyroidism causing accelerated metabolism
  • Severe malnutrition or eating disorders
  • Certain genetic conditions affecting lipid metabolism
  • Liver disease impacting VLDL production

It's important to note that these concerns typically only arise with extremely low levels and are usually accompanied by other symptoms. Most people with low VLDL cholesterol are simply enjoying the benefits of good metabolic health. Your healthcare provider will consider your complete health picture, including other lab values, symptoms, and medical history, when evaluating whether low VLDL levels are cause for concern.

Testing and Monitoring Your VLDL Levels

Regular lipid testing is the best way to monitor your VLDL cholesterol levels along with other important cardiovascular markers. Since VLDL is calculated from your triglyceride levels, any comprehensive lipid panel that includes triglycerides will provide your VLDL estimate. Most healthcare providers recommend lipid testing every 4-6 years for healthy adults, though more frequent testing may be appropriate if you have risk factors for heart disease or are making lifestyle changes to improve your cholesterol levels.

When reviewing your lipid panel results, it's helpful to look at VLDL in context with your other cholesterol markers. A comprehensive view includes total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and increasingly, advanced markers like Apolipoprotein B (ApoB) and Lipoprotein(a). These additional markers can provide deeper insights into your cardiovascular risk, especially if you have a family history of heart disease or other risk factors.

Understanding Your Complete Lipid Profile

Your VLDL level is just one piece of the cardiovascular health puzzle. For optimal heart health, aim for a balanced lipid profile with LDL cholesterol below 100 mg/dL (or below 70 mg/dL if you have cardiovascular disease), HDL cholesterol above 40 mg/dL for men or 50 mg/dL for women, and triglycerides below 150 mg/dL. When all these markers are in healthy ranges, including low VLDL, you're well-positioned for long-term cardiovascular health.

Maintaining Healthy VLDL Levels Through Lifestyle

If you already have low VLDL cholesterol, maintaining these healthy levels through lifestyle choices can help protect your cardiovascular health long-term. The same strategies that help lower high VLDL can help you maintain optimal levels.

Dietary Strategies

Focus on whole, unprocessed foods rich in fiber, lean proteins, and healthy fats. The Mediterranean diet pattern, which emphasizes olive oil, fish, nuts, whole grains, and plenty of fruits and vegetables, has been shown to maintain healthy VLDL and triglyceride levels. Limit refined sugars and processed carbohydrates, as these can trigger increased VLDL production even in people with normally healthy levels.

  • Choose whole grains over refined grains
  • Include fatty fish like salmon or sardines twice weekly
  • Limit added sugars to less than 25-36 grams daily
  • Incorporate nuts, seeds, and avocados for healthy fats
  • Fill half your plate with non-starchy vegetables

Exercise and Physical Activity

Regular physical activity helps maintain low VLDL levels by improving your body's ability to use triglycerides for energy. Aim for at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous exercise weekly, along with strength training exercises at least twice per week. Even modest increases in daily activity, like taking the stairs or walking during lunch breaks, can help maintain healthy lipid levels.

The Bottom Line on Low VLDL Cholesterol

Low VLDL cholesterol is typically a sign of good cardiovascular health rather than a cause for concern. Unlike many health markers where both high and low values can be problematic, VLDL is one where lower is generally better—within reason. Most people with low VLDL levels are benefiting from healthy lifestyle choices, good genetics, or both.

However, context matters in interpreting any lab value. If you have extremely low VLDL levels along with other unusual lab results or symptoms, it's worth discussing with your healthcare provider. For most people, though, low VLDL cholesterol is something to maintain rather than worry about. Continue focusing on heart-healthy lifestyle choices, get regular lipid testing to monitor your levels, and work with your healthcare team to maintain optimal cardiovascular health for years to come.

References

  1. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.[Link][PubMed][DOI]
  2. Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547-563.[Link][PubMed][DOI]
  3. Packard CJ, Boren J, Taskinen MR. Causes and consequences of hypertriglyceridemia. Front Endocrinol. 2020;11:252.[Link][PubMed][DOI]
  4. Ginsberg HN, Packard CJ, Chapman MJ, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies. Eur Heart J. 2021;42(47):4791-4806.[Link][PubMed][DOI]
  5. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40(2):537-557.[Link][PubMed][DOI]
  6. Ramasamy I. Update on the laboratory investigation of dyslipidemias. Clin Chim Acta. 2018;479:103-125.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL cholesterol at home?

You can test your VLDL cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing with VLDL calculations, along with advanced markers like ApoB and Lipoprotein(a) for complete cardiovascular assessment.

What is the ideal VLDL cholesterol level?

The ideal VLDL cholesterol level is typically below 30 mg/dL, with many experts suggesting that levels between 5-20 mg/dL are optimal for cardiovascular health. VLDL below 2 mg/dL may warrant investigation for underlying conditions.

Can VLDL cholesterol be too low?

While low VLDL is generally healthy, extremely low levels (below 2 mg/dL) combined with very low triglycerides (below 35 mg/dL) might indicate malabsorption, hyperthyroidism, or nutritional issues and should be evaluated by a healthcare provider.

How is VLDL different from LDL cholesterol?

VLDL primarily carries triglycerides and is larger than LDL particles. As VLDL delivers triglycerides to tissues, it transforms into LDL cholesterol. While both can contribute to heart disease, VLDL is the precursor that becomes the LDL we typically monitor.

What foods help maintain low VLDL levels?

Foods that help maintain low VLDL include fatty fish, whole grains, nuts, olive oil, and plenty of vegetables. Limiting refined sugars, processed foods, and excessive alcohol intake is equally important for keeping VLDL levels healthy.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details